THE CLINICAL IMPACT OF RIVAROXABAN TO CHINESE AT ATRIAL FIBRILLATION PATIENTS RESULTS FROM A SIMPLE COMMUNICATION TOOL

被引：0
|
作者：
Yang, L. [1 ]
Wu, J. J. [2 ]
Zhu, G. [2 ]
Evers, T. [3 ]
机构：
[1] Peking Univ, Beijing 100871, Peoples R China
[2] Bayer Healthcare Co Ltd, Beijing, Peoples R China
[3] Bayer Pharma AG, Wuppertal, Germany
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV143
引用
收藏
页码：A497 / A497
页数：1
相关论文
共 50 条
  • [21] RIVAROXABAN IN PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION
    Simonyi Gabor
    Medvegy Mihaly
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2012, 65 (11-12): : 365 - 368
  • [22] Apixaban vs rivaroxaban in patients with atrial fibrillation
    Reactions Weekly, 2020, 1796 (1) : 7 - 7
  • [23] Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study
    Anguita Sanchez, Manuel
    Marin, Francisco
    Masjuan, Jaime
    Cosin-Sales, Juan
    Vazquez Rodriguez, Jose Manuel
    Barrios, Vivencio
    Baron-Esquivias, Gonzalo
    Lekuona, Inaki
    Perez-Cabeza, Alejandro, I
    Freixa-Pamias, Roman
    Parra Jimenez, Francisco Javier
    Khanji Khatib, Mohamed Monzer
    Rafols Priu, Carles
    Sanmartin Fernandez, Marcelo
    CARDIOLOGY JOURNAL, 2022, 29 (06) : 936 - 947
  • [24] Rivaroxaban in very elderly patients with atrial fibrillation
    Lamaida, Norman
    Cristiano, Giuseppina
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [25] Initial rivaroxaban dosing in patients with atrial fibrillation
    Ablefoni, Kaja
    Buchholz, Alexander
    Ueberham, Laura
    Hilbert, Sebastian
    Dagres, Nikolaos
    Husser, Daniela
    Hindricks, Gerhard
    Bollmann, Andreas
    CLINICAL CARDIOLOGY, 2019, 42 (10) : 873 - 880
  • [26] Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
    Ruff, Christian T.
    Patel, Siddharth M.
    Giugliano, Robert P.
    Morrow, David A.
    Hug, Bruce
    Kuder, Julia F.
    Goodrich, Erica L.
    Chen, Shih-Ann
    Goodman, Shaun G.
    Joung, Boyoung
    Kiss, Robert G.
    Spinar, Jindrich
    Wojakowski, Wojciech
    Weitz, Jeffrey I.
    Murphy, Sabina A.
    Wiviott, Stephen D.
    Parkar, Sanobar
    Bloomfield, Daniel
    Sabatine, Marc S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (04): : 361 - 371
  • [27] Rivaroxaban in very elderly patients with atrial fibrillation
    Lamaida, Norman
    Cristiano, Giuseppina
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G33 - G33
  • [28] Clinical analysis of results of a simple left atrial procedure for chronic atrial fibrillation
    Imai, K
    Sueda, T
    Orihashi, K
    Watari, M
    Matsuura, Y
    ANNALS OF THORACIC SURGERY, 2001, 71 (02): : 577 - 581
  • [29] Oral anticoagulation therapy with rivaroxaban in elderly patients with atrial fibrillation. Results from EMIR study
    Esteve Pastor, M.
    Marin, F.
    Anguita, M.
    Sanmartin, M.
    Rafols, C.
    Roldan, V.
    Perez, C.
    Barrios, V.
    Lekuona Goya, I.
    Perez Cabeza, A.
    Cosin Sales, J.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2811 - 2811
  • [30] Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry
    Beyer-Westendorf, J.
    Camm, A. J.
    Virdone, S.
    Fox, K. A. A.
    Pieper, K. S.
    Le Heuzey, J. -Y.
    Haas, S.
    Kayani, G.
    Gersh, B. J.
    Turpie, A. G. G.
    Kakkar, A. K.
    EUROPEAN HEART JOURNAL, 2021, 42 : 578 - 578
12345